Home / Events / Swiss Biotech Day 2026
Landscape view of mountains in Switzerland, location of Swiss Biotech Day.
Citeline IN-PERSON EVENT

Swiss Biotech Day 2026

Basel, Switzerland

Swiss Biotech Day 2026 is Europe’s premier biotechnology conference, connecting senior leaders to network and explore innovations across R&D, manufacturing, data, AI, and financing.

Citeline, a Swiss Biotech Association member and main sponsor, invites you to visit us at booth #34 to see how we support life sciences leaders with actionable data.

Book a meeting with us on HelloPartnering:

Book a meeting

About the event

Swiss Biotech Day 2026 brings together over 2,500 biotech, pharma, and life sciences professionals worldwide. The conference offers a platform to network, explore innovations, and discuss trends shaping the future of the industry.

Key highlights:

  • Exhibition of cutting-edge technologies and solutions
  • Thematic sessions on R&D, manufacturing, data, AI, and financing
  • One-on-one partnering meetings to connect with collaborator 

Learn more: https://swissbiotechday.ch/

Agenda

MAY 04, 2026
08:00 CET

Joint Citeline-Swiss Biotech Association Executive Breakfast Briefing (by invitation only)

This closed-door session will highlight key pharma R&D trends, followed by a panel discussion exploring cross-border collaborations and strategic opportunities between Europe and China, for a select group of senior leaders.

Please email Mandy Choong at [email protected] if you would like to attend.

MAY 04, 2026
16:30 CET

What’s next in R&D, innovation, and clinical development?

This panel explores how AI and emerging clinical trends are reshaping R&D, from shifting scientific priorities to data-driven decisions and evolving trial designs.

Our experts
Portrait of Daniel Chancellor, Director of Thought Leadership at Citeline.
Daniel Chancellor
VP of Thought Leadership
Norstella
Headshot of Kevin Grogan.
Kevin Grogan
Managing Editor, Scrip
Citeline
Daniel Chancellor
VP of Thought Leadership
 Norstella
Daniel has more than 15 years of experience in the biopharma industry, spanning roles in drug discovery, market analysis, competitive intelligence, and strategic consulting. Beginning his advisory career at Citeline, Daniel now oversees the thought leadership program for Norstella and its constituent companies, producing materials that support clients across a range of hot topics in the biopharma industry. As part of this, Daniel regularly participates in webinars, conferences, and other speaking arrangements, and he has provided expert insights across a wide range of leading industry and business publications.
Kevin Grogan
Managing Editor, Scrip
 Citeline
Kevin Grogan has extensive experience across all areas of the pharmaceutical industry and therapeutic sectors, having interviewed numerous key leaders in the biopharma and biotech spaces. A regular participant and moderator at financial and medical conferences, he brings valuable insights into the discussions shaping the future of the industry. Kevin has also shared his expertise on BBC television and radio, ITV, and Channel 4, providing thought leadership on the latest trends and breakthroughs in the pharmaceutical and biotech sectors.